On Sunday, October 21, 2012 Dr. Matthew McKinley spoke about the importance of hereditary colorectal cancer at the American College of Gastroenterology’s Annual Scientific Meeting in Las Vegas, Nevada.  Myriad employees were on-site after the presentation and took questions about how testing for hereditary colon cancer plays a key role in the treatment of those diagnosed with Lynch syndrome. Both the presentation and the meeting were lively and a great success. There was lots of great discussion regarding hereditary colorectal cancer.

Why is learning about hereditary colorectal cancer important to you?

Why bother with hereditary colon cancer?

—Sarah Watts
Associate Product Manager, Oncology

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.